Exceptional Ventures

VC London, United Kingdom · Founded 2022

Exceptional Ventures invests in early-stage companies globally that are focused on enhancing human longevity, health, and happiness by maximizing 'Joyspanu00ae'u2014the years lived in good health, purpose, and happiness. They prioritize scientifically proven innovations in wellness, risk assessment, early detection, and smarter treatment and care delivery.

About Exceptional Ventures

Exceptional Ventures is a UK-based early-stage venture firm with a stated thesis around human flourishing, longevity, mental health, women’s health, and the broader well-being economy. The firm sits in an emerging category of values-driven generalist funds that have made the bet that consumer and prosumer health, longevity, and behavioral health are durable categories rather than passing themes. Healthcare exposure is significant and central, though weighted toward consumer and digital rather than therapeutics, devices, or hospital enterprise. AI focus is real and applied; expect interest in AI-enabled coaching, personalization, diagnostics-as-a-service, and clinical decision support where the model is the experience rather than a wrapper. Stage is Seed and selective Series A, with initial checks plausibly ranging from USD 250K to USD 1.5M, sometimes leading a small round and often co-investing alongside European seed peers. This is the wrong fit for capital-intensive medtech, regulated drug development, or US-only enterprise health IT. It is a strong fit for European or transatlantic founders building consumer-health, longevity, or mental-health products where engagement, retention, and outcomes can be measured early. Entry path is the LinkedIn page and the firm website, with warm introductions from portfolio founders working materially better than cold inbound. Founders should arrive with crisp evidence on cohort behavior and unit economics; a flourishing narrative without retention data will land flat.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Exceptional Ventures

Tools made by companies in Exceptional Ventures's portfolio that we cover in the directory.

ArteraAI Prostate
Artera
Oncology AI
ArteraAI Prostate is an AI-powered diagnostic test that provides prognostic and predictive insights for localized prostate cancer, aiding in personalized treatment decisions and improving patient outcomes.
Artera (formerly WELL Health)
Artera
Patient Engagement & Education
Artera (formerly WELL Health) provides a unified communication hub for health systems, sitting on top of existing EHR systems to automate workflows, send appointment reminders, and collect patient feedback. The platform aims to deliver the best experience to patients and healthcare staff through seamless, integrated communications, allowing patients to manage healthcare communications from one recognizable phone number and staff to reduce busy work.

Portfolio companies in our directory

Other portfolio companies

Companies in Exceptional Ventures's portfolio not currently in our directory.

  • GlycanAge
  • Bio&Me
  • Roga Life
  • Here We Flo
  • Bar.on
  • Pacifico Biolabs
  • Juniper Health
  • SAVA

Team

Paolo Pio
Co-Founder & General Partner
Matt Cooper
Co-Founder & Executive Chairman
Anna Fortuny-Gomez, PhD
Head of Platform, Science, & Reputation
Joan Miquel Marcos Salleras
Visiting Analyst
Alex Su00f6derman
CFO & Compliance
Frederica Dick-Read
Executive Assistant

Pitch / review this investor

Have you raised from Exceptional Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.